Biomea Fusion, Inc.
Recent Filings
All 273 filings →| Form | Description | Date |
|---|---|---|
| 10-K | 10-K | Mar 24, 2026 |
| 8-K | 8-K | Mar 24, 2026 |
| 8-K | 8-K | Feb 25, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G | — | Feb 12, 2026 |
| SCHEDULE 13G/A | — | Feb 6, 2026 |
| 5 | 5 | Feb 6, 2026 |
| 8-K | 8-K | Jan 14, 2026 |
| S-8 | S-8 | Jan 6, 2026 |
| 4 | 4 | Dec 15, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Erdtmann Rainer M | See Remarks | Purchase | 30,000 @ $1.43 | 723,027 | Dec 11, 2025 |
| Hitchcock Michael J.M. | Interim CEO | Purchase | 100,000 @ $0.99 | 115,000 | Dec 2, 2025 |
| Erdtmann Rainer M | See Remarks | Purchase | 40,000 @ $1.10 | 683,027 | Dec 1, 2025 |
| Valle Franco | Chief Financial Officer | Award / Grant | 495 @ $6.15 | 42,995 | Nov 30, 2024 |
| Hitchcock Michael J.M. | — | Purchase | 10,000 @ $10.06 | 15,000 | Sep 30, 2024 |
| Valle Franco | Chief Financial Officer | Purchase | 12,509 @ $4.43 | 42,500 | May 31, 2024 |
| Frias Juan Pablo | Chief Medical Officer | Award / Grant | 349 @ $8.94 | 349 | May 31, 2024 |
| Valle Franco | Chief Financial Officer | Award / Grant | 1,345 @ $3.78 | 25,543 | Nov 30, 2023 |
| A2A Pharmaceuticals, Inc. | — | Sale | 75,000 @ $33.81 | 3,550,000 | Jun 1, 2023 |
| Valle Franco | Chief Financial Officer | Award / Grant | 4,273 @ $3.78 | 24,198 | May 31, 2023 |